Harald L. Esch

Metabolic activation of PCBs to carcinogens in vivo—A review

Gabriele Ludewig, Leane Lehmann, Harald L. Esch et al. · Environmental Toxicology and Pharmacology · 2007 · 92 citations · Full text

Medicine, Biochemistry, Toxicology +12

Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of Daidzein in cultured human Ishikawa cells

Leane Lehmann, Harald L. Esch, Jörg Wagner et al. · Toxicology Letters · 2005 · 63 citations

Pharmacy, Pharmacology, Toxicology +15

4-Monochlorobiphenyl (PCB3) induces mutations in the livers of transgenic Fisher 344 rats

Leane Lehmann, Harald L. Esch, Patricia Kirby et al. · Carcinogenesis · 2006 · 55 citations · Full text

Pharmacy, Biochemistry, Toxicology +15

Application of a weight of evidence approach to assessing discordant sensitisation datasets: Implications for REACH

David Basketter, Nicholas Ball, Stuart Z. Cagen et al. · Regulatory Toxicology and Pharmacology · 2009 · 50 citations

Education, Data Science, Psychometrics +2

A primaquine–chloroquine hybrid with dual activity against Plasmodium liver and blood stages

Melanie Lödige, Matthew D. Lewis, Eleonora S. Paulsen et al. · International Journal of Medical Microbiology · 2013 · 39 citations

Medicine, Infectious Diseases, Pharmacology +15